Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...

Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...

Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...

A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...

Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...